Page last updated: 2024-09-04

ampelopsin and Heart Diseases

ampelopsin has been researched along with Heart Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, L; Dai, J; Fu, Y; He, Q; Luo, P; Shao, J; Wang, J; Weng, Q; Yang, B; Yang, X; Zhu, H	1

Other Studies

1 other study(ies) available for ampelopsin and Heart Diseases

Article	Year
Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin. Oncotarget, 2015, Feb-20, Volume: 6, Issue:5 Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; Apoptosis; Cell Proliferation; Cytoprotection; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Doxorubicin; Flavonols; Heart Diseases; HL-60 Cells; Humans; K562 Cells; Lymphoma, Large B-Cell, Diffuse; Mice, Inbred BALB C; Mice, Inbred ICR; Myocytes, Cardiac; Nerve Tissue Proteins; Oxidative Stress; Protective Agents; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Protein p53; U937 Cells; Xenograft Model Antitumor Assays	2015

Article

Year

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.

Oncotarget, 2015, Feb-20, Volume: 6, Issue:5

Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; Apoptosis; Cell Proliferation; Cytoprotection; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Doxorubicin; Flavonols; Heart Diseases; HL-60 Cells; Humans; K562 Cells; Lymphoma, Large B-Cell, Diffuse; Mice, Inbred BALB C; Mice, Inbred ICR; Myocytes, Cardiac; Nerve Tissue Proteins; Oxidative Stress; Protective Agents; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Protein p53; U937 Cells; Xenograft Model Antitumor Assays

2015